234 related articles for article (PubMed ID: 19339805)
21. Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires.
Petersen KD; Kronborg C; Gyrd-Hansen D; Dahl R; Larsen JN; Løwenstein H
Allergy; 2008 Mar; 63(3):284-91. PubMed ID: 18269674
[TBL] [Abstract][Full Text] [Related]
22. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines.
Bousquet PJ; Combescure C; Neukirch F; Klossek JM; Méchin H; Daures JP; Bousquet J
Allergy; 2007 Apr; 62(4):367-72. PubMed ID: 17362246
[TBL] [Abstract][Full Text] [Related]
23. Classification and management of allergic rhinitis patients in general practice during pollen season.
Van Hoecke H; Vastesaeger N; Dewulf L; Sys L; van Cauwenberge P
Allergy; 2006 Jun; 61(6):705-11. PubMed ID: 16677239
[TBL] [Abstract][Full Text] [Related]
24. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma.
Antonicelli L; Micucci C; Voltolini S; Feliziani V; Senna GE; Di Blasi P; Visonà G; De Marco R; Bonifazi F
Clin Exp Allergy; 2007 Jun; 37(6):954-60. PubMed ID: 17517110
[TBL] [Abstract][Full Text] [Related]
25. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis.
Ciprandi G; Cirillo I; Pistorio A; Di Gioacchino M; Fenoglio D
J Biol Regul Homeost Agents; 2009; 23(1):31-6. PubMed ID: 19321044
[TBL] [Abstract][Full Text] [Related]
26. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items.
Valero A; Ferrer M; Sastre J; Navarro AM; Monclús L; Martí-Guadaño E; Herdman M; Dávila I; Del Cuvillo A; Colás C; Baró E; Antépara I; Alonso J; Mullol J
J Allergy Clin Immunol; 2007 Aug; 120(2):359-65. PubMed ID: 17531304
[TBL] [Abstract][Full Text] [Related]
27. Allergic rhinitis management pocket reference 2008.
Bousquet J; Reid J; van Weel C; Baena Cagnani C; Canonica GW; Demoly P; Denburg J; Fokkens WJ; Grouse L; Mullol K; Ohta K; Schermer T; Valovirta E; Zhong N; Zuberbier T
Allergy; 2008 Aug; 63(8):990-6. PubMed ID: 18691301
[TBL] [Abstract][Full Text] [Related]
28. [Multicenter study of satisfaction with fast-dissolving ebastine, 20 mg/ day, in Mexican patients with allergic rhinitis].
Aguilar D; Arias A; Báez C; González S; Hernández D; Linares FJ; López A; Macías A; Martínez A; Martínez HM; Martínez N; Mogica MD; Paz D; Rojo I; Sánchez A
Rev Alerg Mex; 2009; 56(2):36-40. PubMed ID: 19526952
[TBL] [Abstract][Full Text] [Related]
29. Severity and impairment of allergic rhinitis in patients consulting in primary care.
Bousquet J; Neukirch F; Bousquet PJ; Gehano P; Klossek JM; Le Gal M; Allaf B
J Allergy Clin Immunol; 2006 Jan; 117(1):158-62. PubMed ID: 16387600
[TBL] [Abstract][Full Text] [Related]
30. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
Bousquet J; Ansótegui I; Canonica GW; Zuberbier T; Baena-Cagnani CE; Bachert C; Cruz AA; González SN; Kuna P; Morais-Almeida M; Mullol J; Ryan DP; Sánchez-Borges M; Valiente R; Church MK
Curr Med Res Opin; 2012 Jan; 28(1):131-9. PubMed ID: 22149770
[TBL] [Abstract][Full Text] [Related]
31. Impact on quality of life during an allergen challenge research trial.
Ellis AK; Day JH; Lundie MJ
Ann Allergy Asthma Immunol; 1999 Jul; 83(1):33-9. PubMed ID: 10437814
[TBL] [Abstract][Full Text] [Related]
32. Rupatadine in allergic rhinitis and chronic urticaria.
Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
[TBL] [Abstract][Full Text] [Related]
33. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma.
Antonicelli L; Micucci C; Voltolini S; Senna GE; Di Blasi P; Visonà G; De Marco R; Bonifazi F
Allergy; 2007 Sep; 62(9):1064-70. PubMed ID: 17686109
[TBL] [Abstract][Full Text] [Related]
34. Effects of dimethindene maleate nasal spray on the quality of life in seasonal allergic rhinitis.
Kirchhoff CH; Kremer B; Haaf-von Below S; Kyrein HJ; Mösges R
Rhinology; 2003 Sep; 41(3):159-66. PubMed ID: 14579656
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
36. [Clinical efficacy of Ebastine under placebo-controlled outdoors clinical study on cedar pollinosis].
Asaka H; Yoshida H; Baba K
Arerugi; 2002 Apr; 51(4):357-63. PubMed ID: 12014026
[TBL] [Abstract][Full Text] [Related]
37. Spreading and impact of the World Health Organization's Allergic Rhinitis and its impact on asthma guidelines in everyday medical practice in France. Ernani survey.
Demoly P; Concas V; Urbinelli R; Allaert FA
Clin Exp Allergy; 2008 Nov; 38(11):1803-7. PubMed ID: 18721255
[TBL] [Abstract][Full Text] [Related]
38. Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine-controlled study of Butterbur extract Ze 339.
Schapowal A;
Phytother Res; 2005 Jun; 19(6):530-7. PubMed ID: 16114089
[TBL] [Abstract][Full Text] [Related]
39. Targeted intervention programs: creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population.
Gregory C; Cifaldi M; Tanner LA
Am J Manag Care; 1999 Apr; 5(4):485-96. PubMed ID: 10387387
[TBL] [Abstract][Full Text] [Related]
40. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
Storms WW
Drugs; 1996; 52 Suppl 1():20-5. PubMed ID: 8828022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
